DMS Imaging
(formerly ASIT Biotech)
(Euronext Brussels and Paris – BE0974289218 – DMSIM)
a specialist in the development, design and manufacture of imaging systems, announces the availability today of its annual financial report for the financial year ended December 31, 2021.
The 2021 annual financial report can be consulted on the company’s website, www.asitbiotech.com, in the “Financial information” section of the Investors area.
About DMS Imaging
(formerly ASIT biotech)
Specialized in high technology in the service of medical diagnosis, DMS Imaging is now positioned as the French leader in the development, design and manufacture of imaging systems dedicated to radiology, bone densitometry, 3D modeling and posturology.
DMS Imaging is listed on the Euronext market in Brussels and Paris (ISIN: BE0974289218 – ticker: DMSIM).
More information on www.asitbiotech.com.
contacts
DMS Imaging
Samuel SANCERNI | General director | +33 4 67 50 49 00 |
Delphine de COURSON | CFO | +33 4 67 50 49 00 |
FINANCE NEWS
Mathieu OMNES | Investor Relations | +33 1 53 67 36 92 |
Fatou-Kine N’DIAYE | Press relations | +33 1 53 67 36 34 |
This publication has the service “? Actusnews SECURITY MASTER”.
– SECURITY MASTER Key:
mJyflZlmYmydm5ybY8qWmWWWZ25qlGXIbJLImmOcl5jFmZ1mnZySZ8nLZnBlmGxn
– To check this key:
https://www.security-master-key.com.
Regulated information:
Press releases for the availability of documents:
– Methods of making available the annual financial and annual audit reports
Full and original press release in PDF format:
https://www.actusnews.com/news/74371-dms-imaging_mad-rfa-2021_29042022.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com